Eli Lilly Achieves Historic £800 Billion Valuation as Mounjaro Sales Drive Market Dominance
Eli Lilly has become the first healthcare company to reach a $1 trillion (£800 billion) market valuation, joining an exclusive…
Eli Lilly has become the first healthcare company to reach a $1 trillion (£800 billion) market valuation, joining an exclusive…
The growing use of GLP-1 medications, such as Mounjaro (tirzepatide), alongside corticosteroids has created practical questions for patients managing multiple…
The UK’s Advertising Standards Authority has stepped in to ban a series of social media adverts promoting weight-loss drugs, saying…
North Wales Police executed a significant enforcement operation in the Llanrwst area, seizing 48 capsules of Mounjaro valued at over…
Lorraine Kelly was clearly impressed during a recent broadcast as one of her regular contributors revealed a remarkable four-stone weight…
A small but startling new study reveals how Tirzepatide may quiet intense food cravings at least for a while. The…
If you’ve been following the wave of GLP‑1 and related weight‑management medications across the UK, you might have come across…
As GLP-1 medicines continue reshaping the weight-management landscape, two private prescription providers , SheMed and Voy , have gained significant…
With GLP-1 weight-loss drugs like Wegovy (semaglutide) and Mounjaro (tirzepatide) attracting growing demand, private providers such as SheMed and MedExpress…
The conversation around modern weight-management treatments has shifted dramatically in recent years. GLP-1 receptor agonists such as semaglutide and tirzepatide,…